320 related articles for article (PubMed ID: 33385486)
21. Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis.
Carter JV; Galbraith NJ; Yang D; Burton JF; Walker SP; Galandiuk S
Br J Cancer; 2017 Mar; 116(6):762-774. PubMed ID: 28152545
[TBL] [Abstract][Full Text] [Related]
22. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
23. Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression.
Kandhavelu J; Subramanian K; Khan A; Omar A; Ruff P; Penny C
Microrna; 2019; 8(1):68-75. PubMed ID: 30073936
[TBL] [Abstract][Full Text] [Related]
24. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
[TBL] [Abstract][Full Text] [Related]
25. Functional role of a long non-coding RNA LIFR-AS1/miR-29a/TNFAIP3 axis in colorectal cancer resistance to pohotodynamic therapy.
Liu K; Yao H; Wen Y; Zhao H; Zhou N; Lei S; Xiong L
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2871-2880. PubMed ID: 29807108
[TBL] [Abstract][Full Text] [Related]
26. Identification of candidate genes and miRNAs for sensitizing resistant colorectal cancer cells to oxaliplatin and irinotecan.
Poorebrahim M; Sadeghi S; Ghanbarian M; Kalhor H; Mehrtash A; Teimoori-Toolabi L
Cancer Chemother Pharmacol; 2020 Jan; 85(1):153-171. PubMed ID: 31781855
[TBL] [Abstract][Full Text] [Related]
27. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.
Miyoshi J; Toden S; Yoshida K; Toiyama Y; Alberts SR; Kusunoki M; Sinicrope FA; Goel A
Sci Rep; 2017 Mar; 7():43393. PubMed ID: 28262692
[TBL] [Abstract][Full Text] [Related]
28. An update on miRNAs as biological and clinical determinants in colorectal cancer: a bench-to-bedside approach.
Weng W; Feng J; Qin H; Ma Y; Goel A
Future Oncol; 2015; 11(12):1791-808. PubMed ID: 26075447
[TBL] [Abstract][Full Text] [Related]
29. [Mechanisms and clinical uses of miRNAs in colorectal cancer].
Ogawa Y; Mimori K
Nihon Rinsho; 2016 Nov; 74(11):1807-1811. PubMed ID: 30550686
[TBL] [Abstract][Full Text] [Related]
30. Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer.
Hibner G; Kimsa-Furdzik M; Francuz T
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262723
[TBL] [Abstract][Full Text] [Related]
31. MicroRNAs and Apoptosis in Colorectal Cancer.
Wang H
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32731413
[TBL] [Abstract][Full Text] [Related]
32. Oncogenic miRNAs and target therapies in colorectal cancer.
Saberinia A; Alinezhad A; Jafari F; Soltany S; Akhavan Sigari R
Clin Chim Acta; 2020 Sep; 508():77-91. PubMed ID: 32407782
[TBL] [Abstract][Full Text] [Related]
33. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
Luo X; Wu Y; Ji M; Zhang S
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA target for MACC1 and CYR61 to inhibit tumor growth in mice with colorectal cancer.
Wang G; Gu J; Gao Y
Tumour Biol; 2016 Oct; 37(10):13983-13993. PubMed ID: 27492459
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-Assisted Hormone Cell Signaling in Colorectal Cancer Resistance.
Massaro C; Safadeh E; Sgueglia G; Stunnenberg HG; Altucci L; Dell'Aversana C
Cells; 2020 Dec; 10(1):. PubMed ID: 33396628
[TBL] [Abstract][Full Text] [Related]
36. MicroRNAs as potential therapeutic targets to predict responses to oxaliplatin in colorectal cancer: From basic evidence to therapeutic implication.
Moradi Marjaneh R; Khazaei M; Ferns GA; Avan A; Aghaee-Bakhtiari SH
IUBMB Life; 2019 Oct; 71(10):1428-1441. PubMed ID: 31322820
[TBL] [Abstract][Full Text] [Related]
37. Identification of microRNAs and their Endonucleolytic Cleavaged target mRNAs in colorectal cancer.
Zhou F; Tang D; Xu Y; He H; Wu Y; Lin L; Dong J; Tan W; Dai Y
BMC Cancer; 2020 Mar; 20(1):242. PubMed ID: 32293320
[TBL] [Abstract][Full Text] [Related]
38. Dysregulated microRNAs in colorectal carcinogenesis: New insight to cell survival and apoptosis regulation.
Anvarnia A; Mohaddes-Gharamaleki F; Asadi M; Akbari M; Yousefi B; Shanehbandi D
J Cell Physiol; 2019 Dec; 234(12):21683-21693. PubMed ID: 31131450
[TBL] [Abstract][Full Text] [Related]
39. Interactions among lncRNAs, miRNAs and mRNA in colorectal cancer.
Tang XJ; Wang W; Hann SS
Biochimie; 2019 Aug; 163():58-72. PubMed ID: 31082429
[TBL] [Abstract][Full Text] [Related]
40. Frontiers of MicroRNA Signature in Non-small Cell Lung Cancer.
Zhu X; Kudo M; Huang X; Sui H; Tian H; Croce CM; Cui R
Front Cell Dev Biol; 2021; 9():643942. PubMed ID: 33898432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
